0001384101-21-000074.txt : 20210505 0001384101-21-000074.hdr.sgml : 20210505 20210505164100 ACCESSION NUMBER: 0001384101-21-000074 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210503 FILED AS OF DATE: 20210505 DATE AS OF CHANGE: 20210505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EASTHAM KARIN CENTRAL INDEX KEY: 0001231845 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36156 FILM NUMBER: 21894052 MAIL ADDRESS: STREET 1: C/O BURNHAM INSTITUTE FOR MEDICAL RESEAR STREET 2: 10901 N. TORREY PINES ROAD CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERACYTE, INC. CENTRAL INDEX KEY: 0001384101 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 205455398 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 243-6300 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: CALDEROME INC DATE OF NAME CHANGE: 20061219 4 1 wf-form4_162024723253740.xml FORM 4 X0306 4 2021-05-03 0 0001384101 VERACYTE, INC. VCYT 0001231845 EASTHAM KARIN 6000 SHORELINE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2021-05-03 4 S 0 3527 48.0135 D 9700 I By IRA Common Stock 2021-05-03 4 S 0 650 48.9985 D 9050 I By IRA Common Stock 2021-05-03 4 S 0 250 50.028 D 8800 I By IRA The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 25, 2020. Represents weighted average sales price. Sale prices for the transactions range from $47.54 to $48.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Represents weighted average sales price. Sale prices for the transactions range from $48.55 to $49.22. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Represents weighted average sales price. Sale prices for the transactions range from $49.92 to $50.10. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. /s/ Keith S. Kennedy, as Attorney-in-fact 2021-05-05